The Accuracy of using Antibiotics with the Gyssens Method on MDRO Events and its Impact on Cost Effectiveness Analysis (CEA) and Length of stay at RSUD dr. Iskak Tulungagung
DOI:
https://doi.org/10.30994/jceh.v7i2.572Keywords:
Cost Effective Analysis, Gyssens, Length of Stay, MDROAbstract
Evaluation of antibiotics in terms of the quality of antibiotic use was carried out using the Gyssens method to evaluate the accuracy of the use of MDRO incidence antibiotics. The purpose of the study was to analyze the effect of the accuracy of antibiotic use on the incidence of MDRO and its impact on cost effectiveness analysis (CEA) and length of stay at Dr. Iskak Hospital Tulungagung. Research design in the form of quantitative research with case control analytical observational research methods with a retrospective approach. The research samples were some employees at RSUD dr. Iskak Tulunggung Regency as many as 50 case groups and 50 control groups with sampling techniques using the simple random sampling method. Data analysis using Path Analysis. The results showed that the punctuality variable of antibiotic administration had an indirect influence on the variable length of hospitalization days of -0.065, indicating that the timeliness of antibiotic administration would affect the length of hospitalization days must pass the MDRO incidence of -0.194. The variable accuracy of antibiotic administration has a direct effect on the length of days of treatment by -0.522. The variables of timeliness of antibiotic administration and the accuracy of the duration of antibiotic administration have a direct influence on the cost effective analysis of -0.191 and -0.426 without passing the MDRO event. Revise antibiogram guidelines, Increase monitoring activities for the use of antibiotics regularly, Increase teamwork of health professionals in an effort to improve the quality of antibiotic use and prevention of MDRO.
Downloads
References
Aulia. (2017). Evaluasi Penggunaan antibiotic pada Pasien Pneumonia di Rumah PKU Muhammadiyah Bantul. Universitas Muhammadiyah Yogyakarta.
CHINET. (2021). China antimicrobial surveillance network annual report.
Enjelina. (2021). Evaluasi Penggunaan Antibiotik secara Kuantitatif dan Kualitatif pada Pasien Bedah Digestif di RSUD Abdul Wahab Sjahranie Samarinda. Proceeding of Mulawarman Pharmaceuticalas Conferences. https://prosiding.farmasi.unmul.ac.id.
Handayani. (2017). Antimicrobial Resistence and its Control Policy Implementation in Hospital in Indonesia. Jurnal Penelitian Dan Pengembangan Pelayanan Kesehatan, 1(2), 131–140.
Idacahyati. (2020). Cost Minimize Analysis Penggunaan Antiplatelet Pada Pasien Stroke. Jurnal Ilmiah Farmasi Farmasyifa, 3(2), 113–120.
Kalluru. (2018). Risk Factors for Infection with Multidrug-Resistant Organism. HHS Public Access, 46(3), 341–345. https://doi.org/https://doi.org/10.1016/j.ajic.2017.08.021.
Lat. (2019). A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18, 253–260. https://doi.org/https://doi.org/10.1002/phar.2171.
Lekok. (2020). Guna Antibiotik untuk Kendali Mutu dan Kendali Biaya di Rumah.
Lestari. (2018). Evaluasi Penggunaan Antibiotik di Bangsal Penyakit dalam RSUD Prof.dr. Margono Soekarjo Purwokerto. Act a Pharmaciae Indonesia, 6(1), 20–28. https://doi.org/https://doi.org/10.22146/jkesvo.30330.
Luo, Y. (2023). Appropriateness of Empirical Antibiotic Therapy in Hospitalized Patients with Bacterial Infection: A Retrospective Cohort Study. Dovepress, 16, 4555–4568. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350404/pdf/idr-16-4555.pdf.
Megawati. (2020). Gambaran Biaya Pasien Umum Rawat Inap Diabetes Mellitus Di Rumah Sakit Umum Ari Canti Periode Tahun 2017. Jurnal Ilmiah Medicamento, 5(1), 21–26. https://doi.org/https://doi.org/10.36733/medicamento.v5i1.836.
Mei-Sheng. (2021). Implementing an antimicrobial stewardship program in the intensive care unit by engaging critical care nurses. Crit. Care Nurs. Clin. North, 33, 369–380. https://doi.org/https://doi.org/10.1016/j.cnc.2021.07.001.
Nalang. (2018). Analisis Efektivitas Biaya (Cost Effectiveness Analysis) Pengobatan Pneumonia Menggunakan Antibiotik Seftriakson dan Sefotaksim di RSUP Prof. DR. R. D. Kandou Manado. Pharmacon, 7(3), 321–329. Standar Pelayanan Kefarmasian di Rumah Sakit, Pub. L. No. 72 (2016).
Redfield. (2019). Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention. https://doi.org/https://doi.org/CS239559-B.
Shahnaz. (2018). Kajian Farmakoekonomi yang Mendasari Pemilihan Pengobatan di Indonesia. Farmaka, 16(3).
Silvira. (2022). Perbandingan efektivitas penggunaan jenis antibiotik profilaksis pada pasien sectio caesarea di RSU Sylvani Kota Binjai tahun 2020. Jurnal Kedokteran STM (Sains Dan Teknologi Medik), 5, 1–6.
Syamsul. (2019). Pneumonia di Puskesmas Induk Kota Binjai the Evaluation of Rational Antibiotic use in non Pneumonia Acute Respiratory Infections (ARI) at Main Health Centre. Jurnal Dunia Farmasi, 3(3), 106–114.
WHO. (2014). Antimicrobial Resistance Global Report on Surveilance. www.who.int.
Wijaya. (2021). Kajian Penggunaan Antibiotika secara Kualitatif dan Kuantitatif pada Ruangan ICU RSUD Petala Bumi Provinsi Riau. Universitas Andalas.
Zhou, Y. (2021). Clinical signifcance of MDRO screening and infection risk factor analysis in the ICU. Am. J. Transl, 13, 3717–3723.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Community Engagement in Health
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
